11/11/09 repress news
New phase one trial of oral chocolate covered potato chip (CCPC) protocol.
Patients will need to be Her-shey positive by dLISH assay and sodium tolerant. Maximum tolerated dose will be primary endpoint with secondary endpoint overall response according to GIRTH criteria. A similar study will investigate possible enhanced compliance by addition of a "stick".